Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion type Assertion NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_head.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion description "[AMG 925 is a dual FLT3/CDK4 inhibitor with the potential to overcome FLT3 inhibitor resistance in acute myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_provenance.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion evidence source_evidence_literature NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_provenance.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion SIO_000772 25487917 NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_provenance.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion wasDerivedFrom befree-2016 NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_provenance.
- NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_assertion wasGeneratedBy ECO_0000203 NP1246257.RA-nJVf0omfPcKWAhkC7mervLkUjnM8v5jNK_lLAezsdk130_provenance.